Mon, October 16, 2017
Fri, October 13, 2017
Thu, October 12, 2017
Wed, October 11, 2017
Tue, October 10, 2017
Mon, October 9, 2017
Fri, October 6, 2017
Thu, October 5, 2017
Wed, October 4, 2017
Tue, October 3, 2017
Mon, October 2, 2017
Fri, September 29, 2017
Thu, September 28, 2017
Wed, September 27, 2017
Tue, September 26, 2017
Mon, September 25, 2017

Michael Weinstein Initiated (ABT) at Hold and Held Target at $60 on, Oct 6th, 2017


//stocks-investing.news-articles.net/content/201 .. -hold-and-held-target-at-60-on-oct-6th-2017.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Michael Weinstein of JP Morgan, Initiated "Abbott Laboratories" (ABT) at Hold and Held Target at $60 on, Oct 6th, 2017.

Michael has made no other calls on ABT in the last 4 months.



There are 6 other peers that have a rating on ABT. Out of the 6 peers that are also analyzing ABT, 2 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Amit Hazan of "Citigroup" Initiated at Hold and Held Target at $53 on, Thursday, August 17th, 2017
  • David Lewis of "Morgan Stanley" Maintained at Hold with Increased Target to $49 on, Monday, July 10th, 2017


These are the ratings of the 4 analyists that currently disagree with Michael


  • Matthew Taylor of "Barclays" Maintained at Buy with Increased Target to $60 on, Thursday, September 28th, 2017
  • Brittany Henderson of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $56 on, Friday, July 21st, 2017
  • David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $62 on, Friday, July 21st, 2017
  • Christopher Pasquale of "Guggenheim" Initiated at Strong Buy and Held Target at $58 on, Thursday, June 29th, 2017

Publication Contributing Sources